Bed Bath & Beyond, Inc. Distributes Dividend of Warrants to Shareholders
The Warrants have been distributed by the Company’s warrant agent and will be exercisable for cash following the Distribution Date, in accordance with the terms of the warrant agreement, a form of which was filed as an exhibit to the Form 8-A Warrant registration statement with the
Warrant Terms
- Eligibility: Shareholders must be a shareholder of record on the October 2, 2025 Record Date to receive warrants.
- Ratio: Stockholders received one (1) warrant for each ten (10) shares of common stock held as of the Record Date of October 2, 2025, rounded down to the nearest whole number for any fractional warrant. As an example, a shareholder who owns 320 or 327 shares of common stock would receive 32 warrants.
-
Exercise Price: Each warrant entitles the holder to purchase one share of the Company’s common stock at an exercise price of
.$15.50 -
Expiration: The warrants will expire at 5:00 p.m.
New York City time on October 7, 2026, unless the Alternate Expiration Date Price Condition is triggered. -
Alternate Expiration Price Condition: If the Company’s common stock equals or exceeds
for at least 20 trading days out of a 30-trading day period, the Company has the right but not the obligation to accelerate the expiration date of the warrants to the business day immediately following the Alternate Expiration Date.$18.60 - Exercisability: The warrants are exercisable beginning as of the date a registration statement on Form S-3 registering the issuance of the shares upon exercise of the of the warrants has been declared effective by the SEC and may be exercised at any time through the Expiration Date.
Frequently asked questions and answers relating to the warrant dividend distribution are available at https://investors.beyond.com/.
About Bed Bath & Beyond, Inc.
Bed Bath & Beyond, Inc. (NYSE:BBBY), based in
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements include all statements other than statements of historical fact, including but not limited to: our expectations regarding the warrant dividend and distribution; the anticipated Exercise Start Date and Distribution Date for the warrant distribution; if and when the Alternate Expiration Date Price Condition may be satisfied, the potential gross proceeds resulting from warrant exercises; the expected use of proceeds from any proceeds received from warrant exercises; the acceptance to trading of the warrants on the New York Stock Exchange; and the price of those warrants and the existence of a market for those warrants. Additional information regarding factors that could materially affect results and the accuracy of the forward-looking statements contained herein may be found in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 25, 2025, our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025, filed with the SEC on July 29, 2025, and in our subsequent filings with the SEC.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008620079/en/
Investor Relations
ir@beyond.com
pr@beyond.com
Source: Bed Bath & Beyond, Inc.